{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T21:20:14Z","timestamp":1791062414574,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s10620-011-1999-x","type":"journal-article","created":{"date-parts":[[2011,12,6]],"date-time":"2011-12-06T06:29:50Z","timestamp":1323152990000},"page":"250-253","source":"Crossref","is-referenced-by-count":9,"title":["Two Brothers with Skewed Thiopurine Metabolism in Ulcerative Colitis Treated Successfully with Allopurinol and Mercaptopurine Dose Reduction"],"prefix":"10.1007","volume":"57","author":[{"given":"Frank","family":"Hoentjen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Hanauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanne K.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,7]]},"reference":[{"key":"1999_CR1","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/ibd.21221","volume":"16","author":"B Jharap","year":"2010","unstructured":"Jharap B, Seinen ML, de Boer NK, et al. Thiopurine therapy in inflammatory bowel disease patients: analyses of two 8-year intercept cohorts. Inflamm Bowel Dis. 2010;16:1541\u20131549. doi: 10.1002\/ibd.21221 .","journal-title":"Inflamm Bowel Dis"},{"key":"1999_CR2","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0016-5085(00)70140-5","volume":"118","author":"MC Dubinsky","year":"2000","unstructured":"Dubinsky MC, Lamothe S, Yang HY, et al. Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease. Gastroenterology. 2000;118:705\u2013713. doi: S0016508500286216 .","journal-title":"Gastroenterology"},{"key":"1999_CR3","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/gut.48.5.642","volume":"48","author":"C Cuffari","year":"2001","unstructured":"Cuffari C, Hunt S, Bayless T. Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease. Gut. 2001;48:642\u2013646.","journal-title":"Gut"},{"key":"1999_CR4","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1053\/j.gastro.2006.01.046","volume":"130","author":"MT Osterman","year":"2006","unstructured":"Osterman MT, Kundu R, Lichtenstein GR, Lewis JD. Association of 6-thioguanine nucleotide levels and inflammatory bowel disease activity: a meta-analysis. Gastroenterology. 2006;130:1047\u20131053. doi: 10.1053\/j.gastro.2006.01.046 .","journal-title":"Gastroenterology"},{"key":"1999_CR5","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.dld.2006.05.026","volume":"39","author":"LP Gilissen","year":"2007","unstructured":"Gilissen LP, Derijks LJ, Verhoeven HM, et al. Pancytopenia due to high 6-methylmercaptopurine levels in a 6-mercaptopurine treated patient with Crohn\u2019s disease. Dig Liver Dis. 2007;39:182\u2013186. doi: 10.1016\/j.dld.2006.05.026 .","journal-title":"Dig Liver Dis"},{"key":"1999_CR6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00008571-199902000-00006","volume":"9","author":"ES Collie-Duguid","year":"1999","unstructured":"Collie-Duguid ES, Pritchard SC, Powrie RH, et al. The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populations. Pharmacogenetics. 1999;9:37\u201342.","journal-title":"Pharmacogenetics"},{"key":"1999_CR7","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.2174\/138945006779025446","volume":"7","author":"RM Engen","year":"2006","unstructured":"Engen RM, Marsh S, Van Booven DJ, McLeod HL. Ethnic differences in pharmacogenetically relevant genes. Curr Drug Targ. 2006;7:1641\u20131648.","journal-title":"Curr Drug Targ"},{"key":"1999_CR8","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/hmg\/8.2.371","volume":"8","author":"YY Hon","year":"1999","unstructured":"Hon YY, Fessing MY, Pui CH, Relling MV, Krynetski EY, Evans WE. Polymorphism of the thiopurine S-methyltransferase gene in African\u2013Americans. Hum Mol Genet. 1999;8:371\u2013376.","journal-title":"Hum Mol Genet"},{"key":"1999_CR9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/hmg\/8.2.367","volume":"8","author":"MM Ameyaw","year":"1999","unstructured":"Ameyaw MM, Collie-Duguid ES, Powrie RH, Ofori-Adjei D, McLeod HL. Thiopurine methyltransferase alleles in British and Ghanaian populations. Hum Mol Genet. 1999;8:367\u2013370.","journal-title":"Hum Mol Genet"},{"key":"1999_CR10","doi-asserted-by":"crossref","first-page":"814","DOI":"10.7326\/0003-4819-154-12-201106210-00009","volume":"154","author":"RA Booth","year":"2011","unstructured":"Booth RA, Ansari MT, Loit E, et al. Assessment of thiopurine S-methyltransferase activity in patients prescribed thiopurines: a systematic review. Ann Intern Med. 2011;154:814\u2013823. doi: 10.1059\/0003-4819-154-12-201106210-00009 .","journal-title":"Ann Intern Med"},{"key":"1999_CR11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.fpc.0000114745.08559.db","volume":"14","author":"E Schaeffeler","year":"2004","unstructured":"Schaeffeler E, Fischer C, Brockmeier D, et al. Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German\u2013Caucasians and identification of novel TPMT variants. Pharmacogenetics. 2004;14:407\u2013417. doi: 00008571-200407000-00004 .","journal-title":"Pharmacogenetics"},{"key":"1999_CR12","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1111\/j.1572-0241.2008.01848.x","volume":"103","author":"JP Gisbert","year":"2008","unstructured":"Gisbert JP, Gomollon F. Thiopurine-induced myelotoxicity in patients with inflammatory bowel disease: a review. Am J Gastroenterol. 2008;103:1783\u20131800. doi: 10.1111\/j.1572-0241.2008.01848.x .","journal-title":"Am J Gastroenterol"},{"key":"1999_CR13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.dld.2008.01.003","volume":"40","author":"LY Kwan","year":"2008","unstructured":"Kwan LY, Devlin SM, Mirocha JM, Papadakis KA. Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease. Dig Liver Dis. 2008;40:425\u2013432. doi: 10.1016\/j.dld.2008.01.003 .","journal-title":"Dig Liver Dis"},{"key":"1999_CR14","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1046\/j.1365-2036.2002.01353.x","volume":"16","author":"A Ansari","year":"2002","unstructured":"Ansari A, Hassan C, Duley J, et al. Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease. Aliment Pharmacol Ther. 2002;16:1743\u20131750.","journal-title":"Aliment Pharmacol Ther"},{"key":"1999_CR15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2036.2005.02583.x","volume":"22","author":"MP Sparrow","year":"2005","unstructured":"Sparrow MP, Hande SA, Friedman S, et al. Allopurinol safely and effectively optimizes tioguanine metabolites in inflammatory bowel disease patients not responding to azathioprine and mercaptopurine. Aliment Pharmacol Ther. 2005;22:441\u2013446. doi: 10.1111\/j.1365-2036.2005.02583.x .","journal-title":"Aliment Pharmacol Ther"},{"key":"1999_CR16","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.cgh.2006.11.020","volume":"5","author":"MP Sparrow","year":"2007","unstructured":"Sparrow MP, Hande SA, Friedman S, Cao D, Hanauer SB. Effect of allopurinol on clinical outcomes in inflammatory bowel disease nonresponders to azathioprine or 6-mercaptopurine. Clin Gastroenterol Hepatol. 2007;5:209\u2013214. doi: 10.1016\/j.cgh.2006.11.020 .","journal-title":"Clin Gastroenterol Hepatol"},{"key":"1999_CR17","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2036.2009.04221.x","volume":"31","author":"A Ansari","year":"2010","unstructured":"Ansari A, Patel N, Sanderson J, O\u2019Donohue J, Duley JA, Florin TH. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2010;31:640\u2013647. doi: 10.1111\/j.1365-2036.2009.04221.x .","journal-title":"Aliment Pharmacol Ther"},{"key":"1999_CR18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/ard.25.Suppl_6.655","volume":"25","author":"RW Rundles","year":"1966","unstructured":"Rundles RW. Effects of allopurinol on 6-mercaptopurine therapy in neoplastic diseases. Ann Rheum Dis. 1966;25:655\u2013656.","journal-title":"Ann Rheum Dis"},{"key":"1999_CR19","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0140-6736(93)91287-V","volume":"342","author":"P Chocair","year":"1993","unstructured":"Chocair P, Duley J, Simmonds HA, et al. Low-dose allopurinol plus azathioprine\/cyclosporin\/prednisolone, a novel immunosuppressive regimen. Lancet. 1993;342:83\u201384. doi: 0140-6736(93)91287-V .","journal-title":"Lancet"},{"key":"1999_CR20","first-page":"S769","volume":"140","author":"PA Blaker","year":"2011","unstructured":"Blaker PA, Arenas M, Fairbanks L, Irving P, Marinaki AM, Sanderson J. A biochemical mechanism for the role of allopurinol in TPMT inhibition. DDW. 2011;140:S769.","journal-title":"DDW"},{"key":"1999_CR21","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/j.1365-2036.2005.02703.x","volume":"22","author":"JA Duley","year":"2005","unstructured":"Duley JA, Chocair PR, Florin TH. Observations on the use of allopurinol in combination with azathioprine or mercaptopurine. Aliment Pharmacol Ther. 2005;22:1161\u20131162. doi: 10.1111\/j.1365-2036.2005.02703.x .","journal-title":"Aliment Pharmacol Ther"},{"key":"1999_CR22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/FPC.0b013e3282f85e47","volume":"18","author":"RL Roberts","year":"2008","unstructured":"Roberts RL, Gearry RB, Bland MV, et al. Trinucleotide repeat variants in the promoter of the thiopurine S-methyltransferase gene of patients exhibiting ultra-high enzyme activity. Pharmacogenet Genomics. 2008;18:434\u2013438. doi: 10.1097\/FPC.0b013e3282f85e4701213011-200805000-00007 .","journal-title":"Pharmacogenet Genomics"},{"key":"1999_CR23","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00008571-200404000-00006","volume":"14","author":"M Lindqvist","year":"2004","unstructured":"Lindqvist M, Haglund S, Almer S, et al. Identification of two novel sequence variants affecting thiopurine methyltransferase enzyme activity. Pharmacogenetics. 2004;14:261\u2013265. doi: 00008571-200404000-00006 .","journal-title":"Pharmacogenetics"},{"key":"1999_CR24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1365-2125.2009.03405.x","volume":"68","author":"SK Kham","year":"2009","unstructured":"Kham SK, Soh CK, Aw DC, Yeoh AE. TPMT*26 (208F\u00a0\u2192\u00a0L), a novel mutation detected in a Chinese. Br J Clin Pharmacol. 2009;68:120\u2013123. doi: 10.1111\/j.1365-2125.2009.03405.x .","journal-title":"Br J Clin Pharmacol"},{"key":"1999_CR25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1365-2036.2011.04756.x","volume":"34","author":"Y Gonzalez-Lama","year":"2011","unstructured":"Gonzalez-Lama Y, Bermejo F, Lopez-Sanroman A, et al. Thiopurine methyl-transferase activity and azathioprine metabolite concentrations do not predict clinical outcome in thiopurine-treated inflammatory bowel disease patients. Aliment Pharmacol Ther. 2011;34:544\u2013554. doi: 10.1111\/j.1365-2036.2011.04756.x .","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-1999-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,20]],"date-time":"2017-06-20T06:50:38Z","timestamp":1497941438000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-011-1999-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,7]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["1999"],"URL":"https:\/\/doi.org\/10.1007\/s10620-011-1999-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,7]]}}}